2025年7月15日，纳斯达克上市的Autolus Therapeutics PLC披露，其董事会薪酬委员会已根据2025年诱导计划，向60名员工授予股票期权奖励。这些期权允许以每股2.47美元的行权价购买总计360,550股普通股，该价格与2025年7月9日收盘价完全一致。每个期权期限长达十年，归属安排分阶段进行：第一年后归属25%，剩余部分在接下来三年按月等额归属，条件是员工持续在公司任职。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.